These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36839744)

  • 1. Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes.
    Zafar MN; Abuwatfa WH; Husseini GA
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation and release of calcein from herceptin-conjugated eLiposomes.
    Zafar MN; Pitt WG; Husseini GA
    Heliyon; 2024 Mar; 10(6):e27882. PubMed ID: 38524567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting ultrasonic release from eLiposomes.
    Lattin JR; Pitt WG
    J Pharm Sci; 2015 Apr; 104(4):1373-84. PubMed ID: 25641709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-induced calcein release from eLiposomes.
    Lattin JR; Pitt WG; Belnap DM; Husseini GA
    Ultrasound Med Biol; 2012 Dec; 38(12):2163-73. PubMed ID: 23062373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery.
    Javadi M; Pitt WG; Belnap DM; Tsosie NH; Hartley JM
    Langmuir; 2012 Oct; 28(41):14720-9. PubMed ID: 22989347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of eLiposomes as a drug delivery vehicle.
    Lattin JR; Belnap DM; Pitt WG
    Colloids Surf B Biointerfaces; 2012 Jan; 89():93-100. PubMed ID: 21962853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Stability of eLiposomes at Elevated Temperatures.
    Husseini GA; Pitt WG; Javadi M
    Technol Cancer Res Treat; 2015 Aug; 14(4):379-82. PubMed ID: 25261070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonic gene and drug delivery using eLiposomes.
    Javadi M; Pitt WG; Tracy CM; Barrow JR; Willardson BM; Hartley JM; Tsosie NH
    J Control Release; 2013 Apr; 167(1):92-100. PubMed ID: 23352908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review.
    Bahutair WN; Abuwatfa WH; Husseini GA
    Nanomaterials (Basel); 2022 Sep; 12(17):. PubMed ID: 36080088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
    Nikolova MP; Kumar EM; Chavali MS
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
    Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
    Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nested Nanobubbles for Ultrasound-Triggered Drug Release.
    Batchelor DVB; Abou-Saleh RH; Coletta PL; McLaughlan JR; Peyman SA; Evans SD
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):29085-29093. PubMed ID: 32501014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.
    Ashrafizadeh M; Delfi M; Zarrabi A; Bigham A; Sharifi E; Rabiee N; Paiva-Santos AC; Kumar AP; Tan SC; Hushmandi K; Ren J; Zare EN; Makvandi P
    J Control Release; 2022 Nov; 351():50-80. PubMed ID: 35934254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic delivery via escape from the endosome using emulsion droplets and ultrasound.
    Lattin JR; Javadi M; McRae M; Pitt WG
    J Drug Target; 2015 Jun; 23(5):469-79. PubMed ID: 25673266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy.
    Lin CY; Javadi M; Belnap DM; Barrow JR; Pitt WG
    Nanomedicine; 2014 Jan; 10(1):67-76. PubMed ID: 23845926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.
    Abri Aghdam M; Bagheri R; Mosafer J; Baradaran B; Hashemzaei M; Baghbanzadeh A; de la Guardia M; Mokhtarzadeh A
    J Control Release; 2019 Dec; 315():1-22. PubMed ID: 31647978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review on triggered liposomal drug delivery with a focus on ultrasound.
    Moussa HG; Martins AM; Husseini GA
    Curr Cancer Drug Targets; 2015; 15(4):282-313. PubMed ID: 25760762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
    Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
    Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.